Достижения в элиминации кори и краснухи в Республике Беларусь

Достижения в элиминации кори и краснухи в Республике Беларусь

The analysis of measles and rubella surveillance data in Belarus for 2012 - 2015 was presented. Laboratory diagnosis based on revealing of specific IgM antibodies, dynamic of IgG concentration or detection of viral RNA. Virus genotyping was done by sequence analysis of C-terminal region of N gene (f...

Full description

Bibliographic Details
Main Authors:	E. O. Samoilovich, G. V. Semeiko, M. A. Yermalovich, V. P. Shimanovich, E. Yu. Svirchevskaya
Format:	Article
Language:	Russian
Published:	Numikom LLC 2016-08-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	корь краснуха заболеваемость элиминация генотипы вируса achievements in measles and rubella elimination in the republic of belarus’ measles rubella incidence elimination virus genotypes
Online Access:	https://www.epidemvac.ru/jour/article/view/190

Similar Items

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
by: N. T. Tikhonova, et al.
Published: (2017-12-01)

Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.
by: G. M. Daragan, et al.
Published: (2018-04-01)

Global Status Report for the Verification of Measles and Rubella Elimination, 2022
by: Patrick O’Connor, et al.
Published: (2024-08-01)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
by: Hana Saffar, et al.
Published: (2021-03-01)

Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic
by: David N. Durrheim, et al.
Published: (2024-06-01)

On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000–2023, Namibia
by: Balcha G. Masresha, et al.
Published: (2024-08-01)

Analysis of the suspected cases of measles and rubella in Pudong New Area of Shanghai， 2013‒2022
by: WANG Xiao, et al.
Published: (2024-06-01)

Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries
by: Thomas D. Filardo, et al.
Published: (2024-06-01)

Seroprevalence of Measles, Rubella and Mumps Antibodies in Foreign Citizens Registered in Moscow Region (Labour Migrants)
by: T. A. Semenenko, et al.
Published: (2017-06-01)

Tracking Measles and Rubella Elimination Progress—World Health Organization African Region, 2022–2023
by: Balcha G. Masresha, et al.
Published: (2024-08-01)

Re-verifying the elimination of measles, rubella and congenital rubella syndrome in Canada, 2016–2020
by: Myriam Saboui, et al.
Published: (2021-11-01)

Measles and Rubella Elimination in the Western Pacific Region in 2013–2022: Lessons Learned from Progress and Achievements Made during Regional and Global Measles Resurgences
by: Yoshihiro Takashima, et al.
Published: (2024-07-01)

Progress of Measles and Rubella Surveillance in the Context of Measles Elimination in the WHO Eastern Mediterranean Region, 2019–2022
by: Muhammad Farid, et al.
Published: (2024-11-01)

Using Regular High-Quality Serosurveys to Identify and Close National Immunity Gaps—Measles and Rubella Elimination in Japan
by: Tomimasa Sunagawa, et al.
Published: (2024-08-01)

Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region
by: Alba Maria Ropero, et al.
Published: (2024-07-01)

Resurgence of measles virus infection in an eliminated country, Sri Lanka
by: Merennage Anusha Yasanthi Fernando, et al.
Published: (2024-05-01)

Post Vaccine Rubella During a Measles Outbreak: Clinical Case
by: Luísa Graça, et al.
Published: (2021-02-01)

Progress towards Measles and Rubella Elimination in the South-East Asia Region—2013–2023
by: Sudhir Khanal, et al.
Published: (2024-09-01)

Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach
by: James L. Goodson, et al.
Published: (2017-12-01)

Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program
by: Shinsuke Miyano, et al.
Published: (2023-04-01)

Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage
by: A. A. Pozdnyakov, et al.
Published: (2018-10-01)

Development of measles‑rubella surveillance health information system in the working area of health center tanjung selor, bulungan district
by: Andi C. Pertiwi, et al.
Published: (2023-12-01)

Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University
by: Maryam Keshavarz, et al.
Published: (2016-06-01)

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security
by: Adaeze Ogee-Nwankwo, et al.
Published: (2017-12-01)

Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas
by: Jon K. Andrus, et al.
Published: (2024-12-01)

External rapid convenience monitoring of measles–rubella campaign 2017 and lessons learned: Study from a hilly district of North India
by: Devender Kumar, et al.
Published: (2020-01-01)

The Combination Vaccine against Measles
by: M. P. Kostinov
Published: (2020-09-01)

Epidemiology of Laboratory Confirmed Measles and Rubella Outbreaks in Rajasthan
by: Pooja Choudhary, et al.
Published: (2018-08-01)

Measurement of Serum Antibody Titer against Measles in a group of Adults Receiving Measles-Rubella Mass Vaccination
by: Alireza Emami Naeini, et al.
Published: (2011-03-01)

Coverage of the Measles-Rubella mass camping vaccination in southern Tehran, Iran
by: Majd Zadeh SR, et al.
Published: (2005-04-01)

Genetic diversity of rubella virus at the present stage of rubella elimination and congenital rubella prevention programs
by: T. S. Chekhlyaeva, et al.
Published: (2019-11-01)

Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019
by: Emilia Vynnycky, et al.
Published: (2023-12-01)

Epidemiological study to assess the status of measles vaccination in under five children and factors associated, in a peri-urban area, Asudgaon village, in Raigad district, Maharashtra, India
by: Neha Riswadkar, et al.
Published: (2022-01-01)

A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9–12 month old healthy infants
by: Subhash Thuluva, et al.
Published: (2023-12-01)

Assessing the 2019 rubella elimination status in the Russian Federation
by: T. S. Chekhlyaeva, et al.
Published: (2021-12-01)

Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries
by: Mateusz Hasso-Agopsowicz, et al.
Published: (2024-09-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

EVALUATION OF INTENSITY OF HUMORAL IMMUNITY TO MEASLES AND RUBELLA IN PREGNANT WOMEN IN MOSCOW
by: A. V. Nozdracheva, et al.
Published: (2017-06-01)

Immune-Response of Individuals after Immunization with Rubella Vaccine
by: Layla Fouad Ali
Published: (2011-12-01)

Knowledge, Attitude and Practice Regarding the mass Anti-Measles and Rubella Immunization Campaign (2004) in the Population Covered by Tehran University of Medical Sciences
by: K Holakouie Naeini, et al.
Published: (2005-12-01)